Fairvalue-Calculator Fairvalue-Calculator
EN DE

InnoCare Optoelectronics Corporation (6861) Fair Value & Analysis

Healthcare · TW · Market cap 12.6B TWD

Price353.00 TWD
Fair Value84.36 TWD
Upside-76.1%
Quality95/100
Evidence: High Range 63.27 TWD – 105.45 TWD

Fair value as of: Jun 24, 2026

✦ Find undervalued quality stocks — 34,000+ analysed Find stocks →

Analysis

InnoCare Optoelectronics Corporation (6861) currently trades at 353.00 TWD, while our model-based Fair Value estimate is 84.36 TWD — implying the stock looks roughly 76.1% overvalued today. We read business quality at 95/100 (high quality), in the Healthcare sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: high).

About the company

InnoCare Optoelectronics Corporation engages in the design, development, manufacture, and sale of optical instruments and medical devices. It also offers X-ray flat panel detectors sensors for healthcare, veterinary, security, and industrial applications in Taiwan and internationally. It offers thin film transistors and scintillators, and other medical products, as well as accessories, including power and ethernet cables, charger sets, and batteries. InnoCare Optoelectronics Corporation was founded in 2019 and is headquartered in Tainan City, Taiwan.

Open the full interactive analysis →

Similar stocks

Frequently asked questions

Is InnoCare Optoelectronics Corporation (6861) undervalued?
As of Jun 24, 2026, our model estimates a fair value of 84.36 TWD versus a price of 353.00 TWD — about −76% (overvalued). Model-based estimate, not financial advice.
What is the fair value of 6861?
Our 21-model fair value for InnoCare Optoelectronics Corporation is 84.36 TWD (as of Jun 24, 2026), built from audited fundamentals. The current price is 353.00 TWD.
What is the quality score of 6861?
InnoCare Optoelectronics Corporation has a Quality Score of 95/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.